Regulation of miR-200 Family microRNAs and ZEB Transcription Factors in Ovarian Cancer: Evidence Supporting a Mesothelial-To-Epithelial Transition

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2009.08.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of the miR-200 Family in Epithelial-Mesenchymal Transition

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

The ZEB/miR-200 Feedback Loop—a Motor of Cellular Plasticity in Development and Cancer?

EMBO Reports
BiochemistryGeneticsMolecular Biology
2010English

Combinatorial Regulation of Transcription Factors and microRNAs

BMC Systems Biology
Molecular BiologyApplied MathematicsStructural BiologySimulationComputer Science ApplicationsModeling
2010English

The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-Cadherin Transcriptional RepressorsZEB1andZEB2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

RASAL2 Down-Regulation in Ovarian Cancer Promotes Epithelial-Mesenchymal Transition and Metastasis

Oncotarget
Oncology
2014English

Mesothelial-To-Mesenchymal Transition as a Possible Therapeutic Target in Peritoneal Metastasis of Ovarian Cancer

Journal of Pathology
Forensic MedicinePathology
2017English

Synergetic Regulatory Networks Mediated by Oncogene-Driven microRNAs and Transcription Factors in Serous Ovarian Cancer

Molecular BioSystems
BiotechnologyMolecular Biology
2013English

miR-204 Shifts the Epithelial to Mesenchymal Transition in Concert With the Transcription Factors RUNX2, ETS1, and cMYB in Prostate Cancer Cell Line Model

Journal of Cancer Research
2014English

Overexpressed FOXC2 in Ovarian Cancer Enhances the Epithelial-To-Mesenchymal Transition and Invasion of Ovarian Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy